NO912670D0 - Nye derivater av 1-difenylmetyl-piperazin, deres fremstilling og anvendelse som medikament. - Google Patents
Nye derivater av 1-difenylmetyl-piperazin, deres fremstilling og anvendelse som medikament.Info
- Publication number
- NO912670D0 NO912670D0 NO912670A NO912670A NO912670D0 NO 912670 D0 NO912670 D0 NO 912670D0 NO 912670 A NO912670 A NO 912670A NO 912670 A NO912670 A NO 912670A NO 912670 D0 NO912670 D0 NO 912670D0
- Authority
- NO
- Norway
- Prior art keywords
- medicine
- preparation
- new derivatives
- diphenylmethyl piperazine
- diphenylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9009562A FR2665160A1 (fr) | 1990-07-26 | 1990-07-26 | Nouveaux derives de 1-diphenylmethylpiperazine, leur preparation et leur application en tant que medicaments. |
Publications (2)
Publication Number | Publication Date |
---|---|
NO912670D0 true NO912670D0 (no) | 1991-07-08 |
NO912670L NO912670L (no) | 1992-01-27 |
Family
ID=9399130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO91912670A NO912670L (no) | 1990-07-26 | 1991-07-08 | Nye derivater av 1-difenylmetyl-piperazin, deres fremstilling og anvendelse som medikament. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5166205A (no) |
EP (1) | EP0468885A1 (no) |
JP (1) | JPH04234359A (no) |
KR (1) | KR920002581A (no) |
CN (1) | CN1058397A (no) |
AU (1) | AU638856B2 (no) |
CA (1) | CA2047879A1 (no) |
CS (1) | CS235091A3 (no) |
ES (1) | ES2043515B1 (no) |
FR (1) | FR2665160A1 (no) |
HU (1) | HUT58319A (no) |
MX (1) | MX9100378A (no) |
NO (1) | NO912670L (no) |
NZ (1) | NZ239105A (no) |
PL (1) | PL291246A1 (no) |
PT (1) | PT98408A (no) |
ZA (1) | ZA915838B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970005927B1 (ko) * | 1990-10-10 | 1997-04-22 | 쉐링 코포레이션 | 디아릴메틸피페리딘 또는 피페라진의 피리딘 및 피리딘 n-옥사이드 유도체, 이를 함유하는 약제학적 조성물 및 이의 제조방법 |
JPH07504905A (ja) * | 1992-03-23 | 1995-06-01 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗刺激剤として用いるための薬剤 |
CA2132848A1 (en) * | 1992-03-27 | 1993-10-14 | Richard Friary | Unabridged bis-aryl carbinol derivatives, compositions and methods of use |
US5741800A (en) * | 1993-06-22 | 1998-04-21 | Knoll Aktiengesellachaft | Azolyl-cyclic amine derivates with immunomodulatory activity |
GB9312806D0 (en) * | 1993-06-22 | 1993-08-04 | Boots Co Plc | Therapeutic agents |
JP3338913B2 (ja) * | 1993-06-29 | 2002-10-28 | 大鵬薬品工業株式会社 | テトラゾール誘導体 |
USH2007H1 (en) * | 1996-01-19 | 2001-12-04 | Fmc Corporation | Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines |
AU2002241459A1 (en) * | 2000-09-20 | 2002-06-11 | Schering Corporation | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR58146E (fr) * | 1948-05-03 | 1953-09-21 | Dispositif pour le soutènement des mines, et en particulier des galeries | |
GB1184714A (en) * | 1965-12-16 | 1970-03-18 | Science Union & Cie | Di- and Tri-Phenylpropyl Piperazine Derivatives |
US3491098A (en) * | 1967-05-29 | 1970-01-20 | Sterling Drug Inc | 1-((imidazolyl)-lower-alkyl)-4-substituted-piperazines |
US4377578A (en) * | 1976-12-21 | 1983-03-22 | Janssen Pharmaceutica, N.V. | Piperazine derivatives |
US4338453A (en) * | 1980-09-17 | 1982-07-06 | The Upjohn Company | Aminoalkyl-1,2,4-triazoles |
NO155805C (no) * | 1981-02-06 | 1987-06-10 | Ucb Sa | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter. |
FR2601366B1 (fr) * | 1986-07-10 | 1988-11-25 | Andre Buzas | Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant. |
US5043447A (en) * | 1987-04-24 | 1991-08-27 | Syntex Pharmaceuticals, Ltd. | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives |
GB8716313D0 (en) * | 1987-07-10 | 1987-08-19 | Janssen Pharmaceutica Nv | 2-(heterocyclylalkyl)imidazopyridines |
JPH02124871A (ja) * | 1988-07-27 | 1990-05-14 | Dainippon Pharmaceut Co Ltd | 1位が置換された複素環式カルボン酸アミド誘導体 |
FR2672052B1 (fr) * | 1991-01-28 | 1995-05-24 | Esteve Labor Dr | Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments. |
GB9021535D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
-
1990
- 1990-07-26 FR FR9009562A patent/FR2665160A1/fr active Pending
-
1991
- 1991-07-08 NO NO91912670A patent/NO912670L/no unknown
- 1991-07-19 KR KR1019910012343A patent/KR920002581A/ko not_active IP Right Cessation
- 1991-07-22 PT PT98408A patent/PT98408A/pt not_active Application Discontinuation
- 1991-07-24 AU AU81279/91A patent/AU638856B2/en not_active Ceased
- 1991-07-24 EP EP91402056A patent/EP0468885A1/fr not_active Withdrawn
- 1991-07-24 NZ NZ239105A patent/NZ239105A/xx unknown
- 1991-07-25 ZA ZA915838A patent/ZA915838B/xx unknown
- 1991-07-25 ES ES09101739A patent/ES2043515B1/es not_active Expired - Lifetime
- 1991-07-25 MX MX9100378A patent/MX9100378A/es unknown
- 1991-07-25 CA CA002047879A patent/CA2047879A1/fr not_active Abandoned
- 1991-07-25 US US07/735,431 patent/US5166205A/en not_active Expired - Fee Related
- 1991-07-25 PL PL29124691A patent/PL291246A1/xx unknown
- 1991-07-26 CS CS912350A patent/CS235091A3/cs unknown
- 1991-07-26 CN CN91105155A patent/CN1058397A/zh active Pending
- 1991-07-26 JP JP3187717A patent/JPH04234359A/ja active Pending
- 1991-07-26 HU HU912517A patent/HUT58319A/hu unknown
Also Published As
Publication number | Publication date |
---|---|
AU8127991A (en) | 1992-02-06 |
JPH04234359A (ja) | 1992-08-24 |
US5166205A (en) | 1992-11-24 |
CA2047879A1 (fr) | 1992-01-27 |
KR920002581A (ko) | 1992-02-28 |
PL291246A1 (en) | 1992-03-09 |
NO912670L (no) | 1992-01-27 |
AU638856B2 (en) | 1993-07-08 |
NZ239105A (en) | 1993-09-27 |
ZA915838B (en) | 1992-04-29 |
CN1058397A (zh) | 1992-02-05 |
ES2043515A1 (es) | 1993-12-16 |
EP0468885A1 (fr) | 1992-01-29 |
ES2043515B1 (es) | 1994-06-16 |
CS235091A3 (en) | 1992-05-13 |
HU912517D0 (en) | 1992-01-28 |
HUT58319A (en) | 1992-02-28 |
MX9100378A (es) | 1992-02-28 |
PT98408A (pt) | 1992-06-30 |
FR2665160A1 (fr) | 1992-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO874632D0 (no) | Cyclodextrinclathrater av carbacyclinderivater og deres anvendelse som legemiddel. | |
NO934146D0 (no) | Nye derivater av tiopyranopyrrol, deres fremstilling og farmas!ytiske preparater inneholdende forbindelsene | |
DK267489A (da) | 1-deoxy-nojirimycin-derivater, deres fremstilling og anvendelse som laegemidler | |
NO881164L (no) | Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter. | |
DK381985A (da) | 3-pyridylforbindelser, deres fremstilling og anvendelse som laegemiddel | |
DK143284D0 (da) | Thiazolinderivater,deres fremstilling og anvendelse som laegemiddel | |
NO880473L (no) | Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel. | |
DK168786D0 (da) | Hidtil ukendte dopaminderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel | |
DK219685A (da) | Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler | |
DK166590D0 (da) | Substituerede allylaminderivater, deres fremstilling og anvendelse som laegemidler | |
NO912670D0 (no) | Nye derivater av 1-difenylmetyl-piperazin, deres fremstilling og anvendelse som medikament. | |
NO921908D0 (no) | Aminosyreazetidinylsubstituerte pyridonderivater, deres fremstilling og anvendelse som medikamenter | |
NO870639D0 (no) | Benzimidazolderivater og deres anvendelse som fungicider. | |
DK648389D0 (da) | Anthracylin-derivater, deres fremstilling og anvendelse som laegemidler | |
DK627684A (da) | 1,4-naphthoquinolinderivater, deres fremstilling og anvendelse som laegemiddel | |
DK42888A (da) | Arylthiadiazolylsulfonamider og derivater deraf, deres fremstilling og anvendelse som laegemiddel | |
NO803551L (no) | Substituerte 2-amino-3,4-dihydropyridinderivater, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel | |
DK501888A (da) | 6-mercaptopurin-derivater, deres fremstilling og anvendelse som laegemidler | |
NO911465D0 (no) | Fremgangsmaate for fremstilling av 4-(3-(4-oksotiazoldinyl))-butynylaminer og deres anvendelse som medikamenter. | |
NO894516D0 (no) | Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter. | |
DK120889A (da) | 3-(2,3,4,5,6-pentafluorphenoxy)-8-azabicyclooe3.2.1aaoctaner, en fremgangsmaade til deres fremstilling og deres anvendelse som medikamenter | |
DK111987D0 (da) | 4-(2-pyrimidinyl)-1-piperazinyl-hererocycliske carbonylderivater, deres fremstilling og anvendelse som laegemidler | |
DK37787D0 (da) | 2,3-dioxabicyclooe3,3,0aaoctan-derivater og deres anvendelse som laegemidler | |
NO901892D0 (no) | Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter. | |
DK111887D0 (da) | Aromatiske omega-alkylimino-tetrahydro-6h-1,3-thiazin-6-on-derivater, deres fremstilling og anvendelse som laegemidler |